Burow Kristina Insider Trading Activity

Average Profitability

59.17%

Insider Buys Quantity

Insider Buys Sum

$71.43M

Insider Sells Quantity

Insider Sells Sum

Insider Activity of Burow Kristina

According to the SEC Form 4 filings, Burow Kristina, being in a position of

director at Scholar Rock Holding Corporation,
оver the last 12 months, has bought 0 shares, and sold 3053 shares for $164,064,
over all time since 2025-05-29, has bought 0 shares, and sold 8453 shares for $324,574.

Biography of Burow Kristina

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks


Buys	$0	0	0
Sells	$164,064	1	100

Comparison of Insiders on Amount of Buys and Sells

Sector

Industry

Transaction Type

Transaction Date

From

Total Value


2026-07-01	Sale	Scholar Rock Holding Corporation SRRK	director	3,053 0.0026%	$53.74	$164,064	-6.36%
2025-10-27	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		1.92M 1.3366%	$2.61	$5M	-31.23%
2025-05-29	Sale	Scholar Rock Holding Corporation SRRK	director	5,400 0.0057%	$29.72	$160,511	+37.8%
2023-11-14	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		3,357 0.0025%	$11.98	$40,217	+3.37%
2023-11-13	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		31,653 0.0232%	$11.75	$371,923	+2.51%
2023-11-10	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		17,275 0.0124%	$11.49	$198,481	+5.87%
2023-11-09	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		31,079 0.0204%	$10.53	$327,262	+15.57%
2023-11-08	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		92,251 0.0634%	$11.03	$1.02M	+15.05%
2023-11-07	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		30,192 0.0216%	$11.50	$347,208	+5.26%
2023-11-06	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		43,082 0.031%	$11.55	$497,597	+6.66%
2023-11-03	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		22,420 0.0159%	$11.38	$255,140	+2.7%
2023-09-29	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		34,560 0.0301%	$13.98	$483,149	-15.59%
2023-09-28	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		41,951 0.0351%	$13.44	$563,699	-9.91%
2023-09-27	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		24,504 0.0188%	$12.31	$301,644	+0.76%
2023-09-26	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		34,000 0.0248%	$11.73	$398,820	+1.71%
2023-09-25	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		60,740 0.0424%	$11.22	$681,464	+4.43%
2023-09-22	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		40,000 0.0277%	$11.14	$445,600	+7.62%
2023-09-19	Purchase	Neumora Therapeutics, Inc. Common Stock NMRA		1.5M 1.5879%	$17.00	$25.5M	-1.04%
2019-10-16	Purchase	Vir Biotechnology, Inc. VIR	director	2M 8.9051%	$20.00	$40M	+115.34%

Total: 19

Company

About Prismo.pro Ideas Articles Privacy Policy Terms of Service Contact Us

Screener Ideas

Dividend Stocks Blue Chip Stocks Defensive Stocks Growth Stocks Value Stocks Cyclical Stocks Penny Stocks

Stock Tools

Insiders Screener Stocks Screener Top Stocks Stock News Insider Ratio List of All Stocks

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.